Narrative review / 2013
Turmeric shows efficacy against ailments such as lupus nephritis, cancer, diabetes, and irritable bowel syndrome in clinical trials.
This review examines the chemical constituents, biological activities, molecular targets, and clinical potential of turmeric. Curcumin constitutes 2-5% of turmeric, though some activities of turmeric are curcumin-independent. Clinical trials have demonstrated the efficacy of turmeric against human ailments including lupus nephritis, cancer, diabetes, irritable bowel syndrome, acne, and fibrosis.
- Study type
- Narrative review
- Who was studied
- Human clinical trials, animal, and cell models (details not specified)
- What was measured
- Efficacy of turmeric in various diseases, biological activities, and targets
THE PAPER
Multitargeting by turmeric, the golden spice: From kitchen to clinic.
Gupta SC, Sung B, Kim JH, Prasad S, Li S, Aggarwal BB. Mol Nutr Food Res, 2013.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.